Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06032546
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2023-09-05
Brief Title:
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus HIV Receiving Intravenous IV Infusion or Subcutaneous SC Injection of Budigalimab andor ABBV-382
Sponsor:
AbbVie
Organization:
AbbVie